Company & Sponsor Intelligence
University Hospital, Caen
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed4
Countries1
Therapeutic footprint
adhdalzheimersautismepilepsyother_psychiatryschizophrenia
Indexed studies
NCT04548245Markers of Executive Attention Development in Preschoolers
adhd · FranceUNKNOWN
adhd · FranceUNKNOWN
NCT02394444Impact of an Intervention Program on Parenting Stress After Preterm Birth
other_psychiatry · NA
other_psychiatry · NA
NCT01638884Prospective Memory Imaging
alzheimers · FranceNA
alzheimers · FranceNA
NCT02265094Associative Memory in Autism Spectrum Disorder
autism · FranceNA
autism · FranceNA
NCT01022489High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study
schizophrenia · FrancePHASE2, PHASE3
schizophrenia · FrancePHASE2, PHASE3
NCT02832349Impact of Educational Actions on the Quality Of Life of Epileptic Patients
epilepsy · FranceNA
epilepsy · FranceNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →